-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$55.00-15.35% Downside
Alpine Immune Sciences, Inc. Frequently Asked Questions
-
What analysts cover Alpine Immune Sciences, Inc.?
Alpine Immune Sciences, Inc. has been rated by research analysts at Wedbush, Morgan Stanley, Guggenheim, Wolfe Research, Oppenheimer in the past 90 days.